Systematic Review of the Symptom Burden, Quality of Life Impairment and Costs Associated with Peptic Ulcer Disease
To access this article, please choose from the options below
Funding: Writing support was provided by Dr. Catherine Henderson (Research Evaluation Unit, Oxford PharmaGenesis Ltd, Oxford, UK), funded by AstraZeneca R&D Mölndal, Sweden.
Conflict of Interest: Dr. Alan Barkun is a consultant for AstraZeneca Inc. Dr. Grigorios Leontiadis has received speaker honoraria from AstraZeneca, Sanofi-Aventis, GlaxoSmithKline, and Janssen-Cilag.
Authorship: This work is original, and the authors meet the criteria for authorship and accept responsibility for the scientific content of the manuscript.
PII: S0002-9343(09)01068-7
doi:10.1016/j.amjmed.2009.09.031
© 2010 Elsevier Inc. All rights reserved.

